TITLE

OSTEOPOROSIS PREVENTION AMONG PREMENOPAUSAL WOMEN: A REVIEW OF BONE ENHANCEMENT INTERVENTIONS

AUTHOR(S)
Lein Jr., Donald H.; Clark, Diane; Turner, Lori
PUB. DATE
June 2011
SOURCE
American Journal of Health Studies;2011, Vol. 26 Issue 2, p60
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Osteoporosis is associated with painful fractures that result in both personal and societal costs. Osteoporosis-related fractures lead to decreased mobility and increased morbidity including disfigurement and loss of independence. As bone loss begins early in life, young women are advised to start preventive behaviors to achieve optimal peak bone mass. Insufficient numbers of young women participate in activities that promote optimal bone mass development and maintenance. The purpose of this literature review is to examine intervention studies that help young women adopt bone healthy behaviors and suggest possible areas for further research.
ACCESSION #
67311178

 

Related Articles

  • Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society. Kanis, John // Journal of Mid-life Health;Apr-Jun2013, Vol. 4 Issue 2, p129 

    The author discusses the guidelines on postmenopausal osteoporosis in women in India. She explains that the guidelines are aimed at to providing an information platform for the assessment and treatment of osteoporosis in order to direct appropriate treatment to individuals at high fracture risk....

  • Calcium reduced loss of bone mineral density but did not prevent fractures in healthy postmenopausal women. Riddell, Lenore // Evidence Based Nursing;Apr2007, Vol. 10 Issue 2, p53 

    The article presents information on a medical research about the effectiveness of calcium supplements in reducing loss of bone mineral density and preventing fractures in postmenopausal women. The research involved 1,471 healthy postmenopausal women and used a randomized, placebo controlled...

  • Efficacy and safety of alendronate in the prevention of bone loss in renal transplant recipients. Shahbazian, H.; Mowla, K.; Shahbazian, H. B.; Peydayesh, B.; Ehsanpour, A. // Indian Journal of Nephrology;Apr-Jun2007, Vol. 17 Issue 2, p61 

    Background: The rapid loss of bone mass density occurs immediately after transplantation; this contributes to an increased risk for osteoporosis and fractures. The prevention and management of bone loss after renal transplantation is not elucidated thus far. The purpose of this study was to...

  • Repeat Bone Density Tests Questioned.  // Orthopedic Design & Technology;Jan/Feb2014, Vol. 10 Issue 1, p57 

    The article focuses on the findings of the study regarding the repeat bone mineral density (BMD) testing in older men and women. It states that the BMD test for older men and women may not develop the ability to foretell fractures beyond the insight derived from the original bone scan. It notes...

  • Treatment of tibial plateau fractures with high strength injectable calcium sulphate. Yu, Baoqing; Han, Kaiwei; Ma, Hui; Zhang, Chuncai; Su, Jiachan; Zhao, Jie; Li, Jingfeng; Bai, Yushu; Tang, Hao // International Orthopaedics;Aug2009, Vol. 33 Issue 4, p1127 

    The aim of this article is to discuss the clinical efficacy of high strength injectable calcium sulphate (MIIGX3) in the treatment of tibial plateau fractures. Thirty-one patients with tibial plateau fractures treated with MIIGX3 were included. Postoperative radiographic study was used to...

  • bone-loss medication.  // Better Homes & Gardens;Aug2010, Vol. 88 Issue 8, p208 

    The article presents answers to a question about increasing bone density without drugs.

  • Answers. Dr. Andrew Weill | The Integrative MD. WEIL, ANDREW // Prevention;May2014, Vol. 66 Issue 5, p63 

    The article presents an answer to a question on how to overcome with low bone-density.

  • Prevention of Osteoporosis. Fernández-Pareja, Antonio; Hernández-Blanco, Elena; Pérez-Maceda, José Manuel; Rubio, Vicente José Riera; Palazuelos, Javier Haya; Dalmau, José Manasanch // Clinical Drug Investigation;2007, Vol. 27 Issue 4, p227 

    Background: The long-term effects of ossein-hydroxyapatite compound (OHC), a drug used for osteoporosis prevention, have not been previously reported. The aim of this study was to assess the long-term efficacy of OHC in postmenopausal women with bone mineral density (BMD) in the osteopenia...

  • Intravenous Ibandronate in the Treatment of Osteoporosis. Croom, Katherine F.; Scott, Lesley J. // Drugs & Aging;2006, Vol. 23 Issue 12, p997 

    The article focuses on the study of intravenous ibandronate in the treatment of osteoporosis, a progressive disease characterized by decreased bone mass and disordered bone structure. The treatment aims to reduce the risk of fractures, that can be achieved by slowing bone loss and bone mass...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics